Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Graeme S. Steele"'
Autor:
Martin T. King, David D. Yang, Anthony V. D’Amico, Ivan Buzurovic, Thomas C. Harris, Christian V. Guthier, Graeme S. Steele, Martin N. Kathrins, Atish D. Choudhury
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Externí odkaz:
https://doaj.org/article/fcddeb8ff07b4f0ab3327f1a09834c94
Publikováno v:
Urology Case Reports, Vol 16, Iss , Pp 35-37 (2018)
Clear cell tubopapillary renal cell carcinoma (CCTP-RCC) is a distinct histologic subtype of RCC recognized for its unique clinicopathologic and immunohistochemical features. A 72-year-old man with presumed polycystic kidney disease (PKD) and bilater
Externí odkaz:
https://doaj.org/article/b5bccb5b2f204c48aaa429ed2dc1095a
Autor:
Aaron J. Cohen, Graeme S. Steele
Publikováno v:
Urology Case Reports, Vol 8, Iss C, Pp 44-46 (2016)
We report the case of a 51-year-old gentleman presenting with obstructive and irritative urinary symptoms, found to have a large prostate mass on imaging. A radical prostatectomy was performed and pathological diagnosis revealed a 12 cm mammary-type
Externí odkaz:
https://doaj.org/article/b0f1c5bc7b544b55b69e110b9b17176c
Autor:
Graeme S. Steele, Jerome P. Richie
Publikováno v:
The Scientific World Journal, Vol 4, Pp 316-329 (2004)
Externí odkaz:
https://doaj.org/article/c7f9affaf6104a329d6fa5a53462213b
Autor:
Kendrick Yim, Kevin Melnick, Sarah L. Mott, Vani Gupta, Timothy N. Clinton, Filipe L.F. Carvalho, Matthew Mossanen, Graeme S. Steele, Kent Mouw, Michael A. O'Donnell, Mark A. Preston
Publikováno v:
Journal of Urology. 207
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4824782aef432f60725e94ddbb4ab9bc
https://doi.org/10.1097/ju.0000000000002633.14
https://doi.org/10.1097/ju.0000000000002633.14
Autor:
Mark A. Preston, Graeme S. Steele, Adam S. Kibel, Steven L. Chang, Matthias Stopfkuchen-Evans, Jill Steinberg, Jairam R. Eswara, H. Abraham Chiang, Quoc-Dien Trinh, Philip J. Cheng, Jacqueline M. Speed, Peter A. Najjar
Publikováno v:
European Urology Focus. 6:74-80
Background Novel venous thromboembolism (VTE) prophylaxis programs, including postdischarge pharmacologic prophylaxis, have been associated with decreased VTE rates. Such practices have not been widely adopted in managing radical cystectomy (RC) pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ebdce2253b69ba44f7433874985e25d
https://doi.org/10.1016/j.euf.2018.08.025
https://doi.org/10.1016/j.euf.2018.08.025
Autor:
Jonathan Thomas, William Paul Skelton, Parvaneh Fallah, Rohit K. Jain, Praful Ravi, Charlene Mantia, Bradley Alexander McGregor, Pier Vitale Nuzzo, Elio Adib, Talal El Zarif, Catherine Curran, Mark A. Preston, Timothy Nguyen Clinton, Roger Li, Graeme S. Steele, Wassim Kassouf, Dory Freeman, Gregory Russell Pond, Rakesh K. Jain, Guru P. Sonpavde
Publikováno v:
Journal of Clinical Oncology. 40:485-485
485 Background: The renin-angiotensin system (RAS) has been demonstrated to modulate cell proliferation, desmoplasia, angiogenesis and immunosuppression. Angiotensin pathway inhibitors are postulated to favorably reprogram the stroma in part by inhib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f85f89c3cfd4fbc4d724f18f09b15aa
https://doi.org/10.1200/jco.2022.40.6_suppl.485
https://doi.org/10.1200/jco.2022.40.6_suppl.485
Autor:
Guru Sonpavde, Amin Nassar, Joaquim Bellmunt, Xiao X. Wei, Eliezer M. Van Allen, Bradley Alexander McGregor, Kevin Lundgren, David J. Kwiatkowski, Mark Pomerantz, Graeme S. Steele, Kent W. Mouw, Mark A. Preston, Lauren C. Harshman, Atish D. Choudhury, Toni K. Choueiri
Publikováno v:
JCO Precis Oncol
Purpose FGFR3-TACC3 (fibroblast growth factor receptor 3–transforming acidic coiled coil-containing protein 3) fusions have recently been identified as driver mutations that lead to the activation of FGFR3 in bladder cancer and other tumor types an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4a73ea0b9e6c8bb95eb3f96eeadf045
https://doi.org/10.1200/po.18.00013
https://doi.org/10.1200/po.18.00013
Autor:
Matthew Mossanen, Bradley Alexander McGregor, Kamaneh Montazeri, Praful Ravi, G Dranitsaris, K L Kilbridge, Graeme S. Steele, Charlene Mantia, G Sonpavde, Mark A. Preston, C Curran, Jonathan David Thomas
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 39:834.e1-834.e7
To compare healthcare resource utilization (HRU) and costs associated with dose-dense methotrexate, vinblastine, doxorubicin, cisplatin (ddMVAC) and gemcitabine, cisplatin (GC) as neoadjuvant chemotherapy for muscle-invasive bladder cancer (MIBC).Pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::167696e65dadf2f6894bdf9a19c34c4d
https://doi.org/10.1016/j.urolonc.2021.04.032
https://doi.org/10.1016/j.urolonc.2021.04.032
Publikováno v:
Urology Case Reports, Vol 16, Iss, Pp 35-37 (2018)
Urology Case Reports
Urology Case Reports
Clear cell tubopapillary renal cell carcinoma (CCTP-RCC) is a distinct histologic subtype of RCC recognized for its unique clinicopathologic and immunohistochemical features. A 72-year-old man with presumed polycystic kidney disease (PKD) and bilater
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::395a3640d30efb08cd8b30475b10b533
http://www.sciencedirect.com/science/article/pii/S2214442017302322
http://www.sciencedirect.com/science/article/pii/S2214442017302322